2022 CBUNA Recertification Information
CBUNA is accepting recertification applications for those individuals whose certification expires December 31, 2022. Applications should be submitted at least 1 month prior to the expiration date. Click below to read more about the recertification process or to complete the online recertification...
Read the May/June Issue of Urologic Nursing Journal
The May/June 2022 issue of the Urologic Nursing journal is now available. Urologic Nursing is a fully digital publication. All the high-quality clinical features and the latest advances in urologic nursing practice you expect from Urologic Nursing are easily accessible online....
HHS Requests Public Input to Develop Action Plan to Strengthen Primary Health Care
The U.S. Department of Health and Human Services (HHS) is requesting input from healthcare providers and other members of the public about ways the federal government could strengthen primary health care in the United States. The HHS Initiative to Strengthen Primary Health Care aims to establish a federal...
AHRQ Releases Toolkit for Preventing CAUTI, CLABSI in ICUs
The Agency for Healthcare Research and Quality (AHRQ) has released a Toolkit for Preventing CLABSI and CAUTI in ICUs that offers customizable tools and training resources to prevent central line-associated bloodstream infections (CLABSI) and catheter-associated urinary tract infections (CAUTI) in...
SUNA Develops Tools to Support Patient Education Regarding Urologic Procedures
SUNA has developed new tools for clinicians to use to help educate patients about various urologic procedures. The Patient Education Procedure Handouts, which were created by the SUNA Postoperative Care Task Force, provide a brief overview of essential information regarding the care of individuals...
Change in Reprocessing Methods with Certain Karl Storz Urological Endoscopes
On April 1, 2022, Karl Storz issued an Urgent Medical Device Recall Notice regarding certain flexible endoscopes for urological use. On April 4, 2022, the U.S. Food and Drug Administration sent a letter to healthcare providers stating the FDA is continuing to "evaluate the risk of patient infections and...
- ‹ previous
- 2 of 4
- next ›